The limitations of angiotensin converting enzyme (ACE) inhibitors in promoting natriuresis in patients with cor pulmonale discussed by Dr A G Stewart and colleagues (October 1994;49:995-8) should not detract from the potential benefits of ACE blockade in retarding deterioration of left ventricular systolic function in those patients who, as a result of mediation of cigarette smoking in the pathogenesis of chronic obstructive pulmonary disease (COPD) and coronary heart disease, respectively, happen to have left ventricular systolic failure as a coexisting disorder. We should be more vigilant in documenting the association of COPD and left ventricular systolic dysfunction' in patients with cor pulmonale because co-prescription of long term oxygen therapy for cor pulmonale and ACE inhibitors for left ventricular systolic failure2 could improve life expectancy, especially when associated with cessation of cigarette smoking.
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